CryoPort develops leading edge, proprietary, technology-driven shipping and storage products for use in the rapidly growing global biotechnology and biopharmaceutical cold chain. The products developed by CryoPort are essential components of the infrastructure required for the testing, research and end user delivery of temperature-sensitive medicines and biomaterials in an increasingly complex logistical environment. The Company offers a complete end to end shipping solution with its products for pharmaceutical clinical trials, gene biotechnology, transport of infectious materials and dangerous goods and pharmaceutical distribution. It markets its services directly in the Americas, Europe, and Asia. The company was founded in 1999.